said John T. Treace, CEO, Founder and Board Member of Treace. Surgeon design team member, Amber Shane, DPM, FACFAS, Department Chair and Residency Faculty at AdventHealth commented, “The SpeedAkin™ ...
said John T. Treace, CEO, Founder and Board Member of Treace. Surgeon design team member, Amber Shane, DPM, FACFAS, Department Chair and Residency Faculty at AdventHealth commented, “The ...
Quite a few insiders have dramatically grown their holdings in Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) over ...
“We close 2024 with new product announcements and 12% annual revenue growth – positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of ...
“We close 2024 with new product announcements and 12% annual revenue growth – positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of Treace.
"We're excited to expand our best-in-class bunion-focused portfolio with the SpeedAkin implant, furthering our commitment to improving patient outcomes," said John T. Treace, CEO, Founder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results